IDO1 and ovarian carcinoma: Interestingly, the most clinically advanced catalytic inhibitor epacadostat stabilized a non-enzymatic conformation of IDO1 and fostered the proliferation of SKOV-3 cells, a human ovarian cancer cell line constitutively expressing IDO1 (20).